Michael E. Talkowski

Michael E. Talkowski

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Michael E. Talkowski


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Nature
Verified
Journal Article
Open access
PDF file
KKKonrad J. Karczewski
Konrad J. Karczewski
LFLaurent C. Francioli
Laurent C. Francioli
GTGrace Tiao
Grace Tiao
BCBeryl B. Cummings
Beryl B. Cummings
JAJessica Alföldi
Jessica Alföldi
DMDaniel G. MacArthur
Daniel G. MacArthur
Genetic variants that inactivate protein-coding genes are a powerful source of information about the phenotypic consequences of gene disruption: genes that are crucial for the function of an organism will be depleted of such variants in natural populations, whereas non-essential genes will tolerate their accumulation. However, predicted loss-of-function variants are enriched for annotation errors, and tend to be found at extremely low frequencies, so their analysis requires careful variant annotation and very large sample sizes1. Here we describe the aggregation of 125,748 exomes and 15,708 genomes from human sequencing studies into the Genome Aggregation Database (gnomAD). We identify 443,769 high-confidence predicted loss-of-function variants in this cohort after filtering for artefacts caused by sequencing and annotation errors. Using an improved model of human mutation rates, we classify human protein-coding genes along a spectrum that represents tolerance to inactivation, validate this classification using data from model organisms and engineered human cells, and show that it can be used to improve the power of gene discovery for both common and rare diseases.

1 September 2015 in Neuron
Verified
Journal Article
Closed access
JSJan Stefan Sanders
Jan Stefan Sanders
XHXin He
Xin He
AWA. Jeremy Willsey
A. Jeremy Willsey
AEA. Gulhan Ercan-Sencicek
A. Gulhan Ercan-Sencicek
KSKaitlin E. Samocha
Kaitlin E. Samocha
MSMatthew W. State
Matthew W. State

27 May 2020 in Nature
Verified
Journal Article
Open access
PDF file
RCRyan L. Collins
Ryan L. Collins
HBHarrison Brand
Harrison Brand
KKKonrad J. Karczewski
Konrad J. Karczewski
XZXuefang Zhao
Xuefang Zhao
JAJessica Alföldi
Jessica Alföldi
MTMichael E. Talkowski
Michael E. Talkowski
Structural variants (SVs) rearrange large segments of DNA1 and can have profound consequences in evolution and human disease2,3. As national biobanks, disease-association studies, and clinical genetic testing have grown increasingly reliant on genome sequencing, population references such as the Genome Aggregation Database (gnomAD)4 have become integral in the interpretation of single-nucleotide variants (SNVs)5. However, there are no reference maps of SVs from high-coverage genome sequencing comparable to those for SNVs. Here we present a reference of sequence-resolved SVs constructed from 14,891 genomes across diverse global populations (54% non-European) in gnomAD. We discovered a rich and complex landscape of 433,371 SVs, from which we estimate that SVs are responsible for 25–29% of all rare protein-truncating events per genome. We found strong correlations between natural selection against damaging SNVs and rare SVs that disrupt or duplicate protein-coding sequence, which suggests that genes that are highly intolerant to loss-of-function are also sensitive to increased dosage6. We also uncovered modest selection against noncoding SVs in cis-regulatory elements, although selection against protein-truncating SVs was stronger than all noncoding effects. Finally, we identified very large (over one megabase), rare SVs in 3.9% of samples, and estimate that 0.13% of individuals may carry an SV that meets the existing criteria for clinically important incidental findings7. This SV resource is freely distributed via the gnomAD browser8 and will have broad utility in population genetics, disease-association studies, and diagnostic screening.

25 February 2021 in Science
Verified
Journal Article
Closed access
PDF file
PEPeter Ebert
Peter Ebert
PAPeter A. Audano
Peter A. Audano
QZQihui Zhu
Qihui Zhu
BRBernardo Rodriguez-Martin
Bernardo Rodriguez-Martin
DPDavid Porubsky
David Porubsky
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Resolving genomic structural variation: Many human genomes have been reported using short-read technology, but it is difficult to resolve structural variants (SVs) using these data. These genomes thus lack comprehensive comparisons among individuals and populations. Ebertet al.used long-read structural variation calling across 64 human genomes representing diverse populations and developed new methods for variant discovery. This approach allowed the authors to increase the number of confirmed SVs and to describe the patterns of variation across populations. From this dataset, they identified quantitative trait loci affected by these SVs and determined how they may affect gene expression and potentially explain genome-wide association study hits. This information provides insights into patterns of normal human genetic variation and generates reference genomes that better represent the diversity of our species.Science, this issue p.eabf7117

18 August 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JFJack M. Fu
Jack M. Fu
FSF. Kyle Satterstrom
F. Kyle Satterstrom
MPMinshi Peng
Minshi Peng
HBHarrison Brand
Harrison Brand
RCRyan L. Collins
Ryan L. Collins
MTMichael E. Talkowski
Michael E. Talkowski

1 April 2012 in Cell
Verified
Journal Article
Closed access
MTMichael E. Talkowski
Michael E. Talkowski
JRJill A. Rosenfeld
Jill A. Rosenfeld
IBIan Blumenthal
Ian Blumenthal
VPVamsee Pillalamarri
Vamsee Pillalamarri
CCColby Chiang
Colby Chiang
JGJames F. Gusella
James F. Gusella